Literature DB >> 18774289

Bone morphogenetic proteins induce expression of metalloproteinases in melanoma cells and fibroblasts.

Tanja Rothhammer1, Simone Braig, Anja-Katrin Bosserhoff.   

Abstract

Bone morphogenetic proteins are secreted growth factors which belong to the TGFbeta super family. In recent studies, we showed that the expression of BMP-4 and -7 is induced in melanoma cells in comparison to normal melanocytes. Functional analyses revealed that BMPs are inevitable factors for migration and invasion processes of melanoma cells; however, the role of BMPs in degradation and remodelling of the extracellular matrix remained unknown. We discovered that melanoma cell clones with reduced BMP activity, generated by stable transfection with an antisense BMP-4 construct or with the BMP inhibitor chordin, showed reduced expression of MMP-1, -2, -3 and -9. Moreover, BMPs displayed paracrine effects on stromal fibroblasts. Treatment of fibroblasts with BMP-2 or -4 led to increased MMP-1, -2, -3 and -13 expression. These data show that BMPs play an important role in dissemination of tumour cells from the primary tumour, either by enhancing the matrix degrading capacity of melanoma cells themselves or by stimulating tumour surrounding fibroblasts to induce expression of matrix metalloproteinases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18774289     DOI: 10.1016/j.ejca.2008.07.029

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  14 in total

1.  Augmented autocrine bone morphogenic protein (BMP) 7 signaling increases the metastatic potential of mouse breast cancer cells.

Authors:  Hirofumi Sakai; Mutsuo Furihata; Chie Matsuda; Munehisa Takahashi; Hiroshi Miyazaki; Takeo Konakahara; Toru Imamura; Tomoko Okada
Journal:  Clin Exp Metastasis       Date:  2012-01-25       Impact factor: 5.150

2.  BMP7 expression in esophageal squamous cell carcinoma and its potential role in modulating metastasis.

Authors:  Guanghui Xu; Shanhong Tang; Jianjun Yang; Kang Chen; Jianqin Kang; Guohong Zhao; Fan Feng; Xuewen Yang; Lina Zhao; Qun Lu; Li Sun; Liu Hong; Taiqian Gong; Hongwei Zhang
Journal:  Dig Dis Sci       Date:  2013-03-17       Impact factor: 3.199

3.  MicroRNA miR-196a is a central regulator of HOX-B7 and BMP4 expression in malignant melanoma.

Authors:  Simone Braig; Daniel W Mueller; Tanja Rothhammer; Anja-Katrin Bosserhoff
Journal:  Cell Mol Life Sci       Date:  2010-05-18       Impact factor: 9.261

4.  BMP6-induced modulation of the tumor micro-milieu.

Authors:  David Stieglitz; Susanne Lamm; Simone Braig; Lena Feuerer; Silke Kuphal; Peter Dietrich; Stephanie Arndt; Bernd Echtenacher; Claus Hellerbrand; Sigrid Karrer; Anja-Katrin Bosserhoff
Journal:  Oncogene       Date:  2018-08-31       Impact factor: 9.867

5.  Bone morphogenetic protein modulator BMPER is highly expressed in malignant tumors and controls invasive cell behavior.

Authors:  J Heinke; M Kerber; S Rahner; L Mnich; S Lassmann; T Helbing; M Werner; C Patterson; C Bode; M Moser
Journal:  Oncogene       Date:  2011-10-24       Impact factor: 9.867

6.  Clinical and Molecular Phenotyping in Scleromyxedema Pretreatment and Posttreatment With Intravenous Immunoglobulin.

Authors:  Christopher A Mecoli; C Conover Talbot; Andrea Fava; Christopher Cheadle; Francesco Boin; Fredrick M Wigley; Laura K Hummers
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-05-14       Impact factor: 4.794

Review 7.  Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition.

Authors:  Pawina Jiramongkolchai; Philip Owens; Charles C Hong
Journal:  Biochem Soc Trans       Date:  2016-08-15       Impact factor: 5.407

8.  BMP signaling induces cell-type-specific changes in gene expression programs of human keratinocytes and fibroblasts.

Authors:  Michael Y Fessing; Ruzanna Atoyan; Ben Shander; Andrei N Mardaryev; Vladimir V Botchkarev; Krzysztof Poterlowicz; Yonghong Peng; Tatiana Efimova; Vladimir A Botchkarev
Journal:  J Invest Dermatol       Date:  2009-08-27       Impact factor: 8.551

Review 9.  Bone Morphogenic Protein Signaling and Melanoma.

Authors:  Piotr Kraj
Journal:  Curr Treat Options Oncol       Date:  2021-04-17

10.  A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis.

Authors:  J S Blackburn; I Liu; C I Coon; C E Brinckerhoff
Journal:  Oncogene       Date:  2009-09-07       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.